Background: High-output double enterostomies (DESs) result in sodium and fluid loss responsible for frequent episodes of dehydration and hospitalizations. Hydration by enteroclysis (HE) is an alternative to parenteral hydration when the small bowel, or the downstream colon, is accessible and functional.

Methods: A retrospective analysis was conducted on all consecutive patients admitted in our institution with high-output (≥1200 ml per 24 h) DES and access to downstream intestine (including colon), who were treated by enteroclysis between 2015 and 2019. A sodium chloride and bicarbonate solution was instilled through a tube inserted in the colon. The objectives were diuresis >1 L, natriuresis >40 mmol/24 h, and urinary sodium-to-potassium ratio >1.

Results: HE was conducted in 52 patients (24 female, 28 male). Initially, 30 patients received intravenous support. Fifteen patients (50%) were weaned from all parenteral support, of whom 11 of 12 (92%) received fluid and electrolyte support and 4 of 18 (22%) received parenteral nutrition (PN). When intravenous fluids were still required, daily volumes decreased from 2714 ± 1424 to 1578 ± 1000 ml per 24 h (P = .001), as did the energetic intake (NS), from 1439 ± 556 to 1230 ± 362 kcal per 24 h (P = .096).

Conclusion: HE through the efferent intestine limits the requirement for parenteral hydration in patients with high-output DES. For patients with intestinal failure dependent on PN, it reduces daily infused volumes.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ncp.10769DOI Listing

Publication Analysis

Top Keywords

parenteral hydration
12
enteroclysis alternative
8
alternative parenteral
8
hydration patients
8
patients high-output
8
high-output double
8
patients
7
hydration
5
parenteral
5
hydration colonic
4

Similar Publications

Accurate urine sodium measurements at home using Point of Care Testing in patients with Short Bowel Syndrome.

Clin Nutr ESPEN

January 2025

Department of Gastroenterology and Hepatology, Intestinal Failure Unit, Radboud University Medical Centre Nijmegen, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands. Electronic address:

Background And Aims: Measurement of the urine sodium concentration (USC) is a simple procedure that in many patients adequately indicates their hydration status. This is of particular importance in patients suffering from short bowel syndrome (SBS), who may very rapidly dehydrate and are at risk for permanently compromising their kidney function. A point of care test (POCT) that allows reliable measurement of USC would enable these patients to effectively evaluate their sodium- and water balance in the at home setting, thereby avoiding hospital visits and delayed test results.

View Article and Find Full Text PDF

Chronic Intestinal Failure and Short Bowel Syndrome in Adults: The State of the Art.

GE Port J Gastroenterol

December 2024

GENE - Artificial Feeding Team, Gastroenterology Department, Hospital Garcia de Orta, Almada, Portugal.

Background: Short bowel syndrome (SBS) is a devastating malabsorptive condition and the most common cause of chronic intestinal failure (CIF). During the intestinal rehabilitation process, patients may need parenteral support for months or years, parenteral nutrition (PN), or hydration/electrolyte supplementation, as a bridge for the desired enteral autonomy.

Summary: Several classification criteria have been highlighted to reflect different perspectives in CIF.

View Article and Find Full Text PDF

Background/objectives: Home parenteral support (HPS) is the core of chronic intestinal failure (IF) treatment. For legal reasons, HPS in Portugal lags behind other European countries, and only a few patients were taken care of at home by nurses. Now, the legislation has changed, allowing patient self-care.

View Article and Find Full Text PDF

Targeted nanoliposomes of oncogenic protein degraders: Significant inhibition of tumor in lung-cancer bearing mice.

J Control Release

December 2024

College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address:

Article Synopsis
  • Around 60% of non-small cell lung cancer (NSCLC) cases express the epidermal growth factor receptor (EGFR), making it a key target for treatment, but resistance to EGFR inhibitors develops quickly and poses challenges for patients.
  • Researchers are exploring a new approach using a technique called "Proteolysis Targeting Chimeras (PROTACs)" to simultaneously degrade EGFR and Bromodomain-containing protein 4 (BRD4), which has shown promising results in cell tests with significant tumor growth inhibition.
  • A specialized formulation, T-BEPRO, utilizing nanoliposomal carriers for delivering these PROTACs, demonstrated improved drug delivery and efficacy in reducing tumor size in mice, outperforming traditional individual drug treatments
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!